BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//RENCI - ECPv5.4.0.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RENCI
X-ORIGINAL-URL:https://archive.renci.org
X-WR-CALDESC:Events for RENCI
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230822T120000
DTEND;TZID=America/New_York:20230822T130000
DTSTAMP:20260429T081151
CREATED:20230816T203535Z
LAST-MODIFIED:20230816T203535Z
UID:20484-1692705600-1692709200@archive.renci.org
SUMMARY:DataBytes: AI in Target Identification and Drug Discovery — Transforming the Future of Medicine
DESCRIPTION:The National Consortium for Data Science (NCDS)\, is pleased to announce the return of DataBytes\, a free webinar series designed to showcase diverse and innovative work in data science. \nArtificial intelligence (AI) is taking a transformative role in target identification and drug discovery. Today\, AI algorithms can analyze vast\, multi-modal datasets to identify drug targets\, accelerate lead compound discovery\, and optimize drug design. AI is being used by biotechnology companies around the world to compress timelines and improve clinical trial outcomes. Join Kimberly Robasky\, Associate Director of Machine Learning / AI at Arrakis Therapeutics\, to uncover the data-driven revolution in personalized medicine enabled by AI-driven drug development.
URL:https://archive.renci.org/event/databytes-ai-in-target-identification-and-drug-discovery-transforming-the-future-of-medicine/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://archive.renci.org/wp-content/uploads/2023/08/NCDS_Flyer_2023_08_DataBytes_Small-Flyer.png
END:VEVENT
END:VCALENDAR